SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults…

Overview of attention for article published in Respiratory Research, October 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Good Attention Score compared to outputs of the same age and source (70th percentile)

Mentioned by

policy: 1 policy source

twitter: 1 X user

Citations

dimensions_citation: 54 Dimensions

Readers on

mendeley: 98 Mendeley

Summary Policy documents X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 2,956 followers.

SOURCE: a phase 3, multicentre, randomized, double-blind, placebo-controlled, parallel group trial to evaluate the efficacy and safety of tezepelumab in reducing oral corticosteroid use in adults with oral corticosteroid dependent asthma https://t.co/RSDNE

12 Jan 2021

Reply Repost Favourite